Jammu to pioneer India’s first Cannabis Medicine Project

The ‘Cannabis Research Project’ of CSIR-IIIM Jammu, spearheaded by Prime Minister Narendra Modi, marks the first-ever initiative of its kind in India. This groundbreaking project is carried out in partnership with a Canadian firm ‘IndusScan’ with the aim of harnessing the potential of cannabis, a substance known for its abuse potential, for the benefit of humanity, particularly for patients afflicted with neuropathies, cancer, and epilepsy.

The Historic Collaboration Between CSIR-IIIM and IndusScan

The historic scientific agreement signed between CSIR-IIIM and IndusScan holds immense significance not only for J&K but also for the entire nation. It has the potential to revolutionize medicine production, ensuring that the country can produce and export medicines that were previously sourced from foreign countries.

This project will play a significant role in raising awareness about the diverse medicinal applications of this once-abused substance, particularly in providing relief to patients suffering from malignancies and various other diseases.

From the perspective of Atma-Nirbhar Bharat (self-reliant India), once all the necessary approvals are obtained, this initiative will enable the production of high-quality drugs suitable for treating different types of neuropathies, diabetic pains, and more, fostering self-sufficiency in the pharmaceutical sector.

CSIR-IIIM: Pioneering Scientific Research in India

CSIR-IIIM, the oldest scientific research institute in India, boasts a rich history of groundbreaking discoveries, including the identification of mint in the 1960s and its pivotal role in the purple revolution. Now, with the advent of the Cannabis Research Project, CSIR-IIIM is poised to elevate its status even further, cementing its position as a prestigious hub for scientific research in India.

Advancements in Medical Cannabis

Cannabis, a remarkable plant, has led to the approval of several drugs by the FDA, including Marilnol/nabilone and Cesamet, prescribed for managing nausea and vomiting. Sativex is another FDA-approved drug that utilizes cannabis for treating neuropathic pain and spasticity, while Epidiolex, containing Cannabidiol, has shown promising results in treating epilepsy. Furthermore, cannabis is being utilized for various medical purposes in other countries as well.

Key takeaways for competitive examinations

  • Chief Scientist at CSIR-IIIM Jammu: Dr Zabeer Ahmed

Find More Miscellaneous News Here

Recent Posts

Which Indian State has the Highest Number of Cyber Crimes in India?

Did you know that cyber crime is growing faster than many traditional crimes in today’s…

2 hours ago

Which City is known as the Biryani Capital of India?

Did you know that India is home to one of the most loved rice dishes…

8 hours ago

What Are 3D Digital Twins and Why Are Adobe and NVIDIA Betting Big on Them?

Adobe has partnered with NVIDIA to enable 3D digital twin technology for scalable marketing content…

8 hours ago

Jones Act Explained: Why the US Suspended 100-Year-Old Shipping Law

The United States has temporarily waived the 100 year old Jones Act for 60 days.…

9 hours ago

The Golden Road’ Wins Big: William Dalrymple Honored for Reframing Global History

Historian William Dalrymple has won the prestigious Mark Lynton History Prize 2026. He won the…

9 hours ago

Prambanan Temple Restoration: India-Indonesia Partnership Blends Tradition with AI

India and Indonesia have strengthen the cultural ties by collaborating on the restoration of the…

9 hours ago